Hypertension Diagnostics Inc (HDII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -772 | -730 | N/A | -1,220 | -1,226 |
| Depreciation Amortization | 128 | 57 | N/A | 82 | 30 |
| Accounts receivable | 95 | 100 | N/A | -1,090 | -607 |
| Accounts payable and accrued liabilities | 177 | 97 | N/A | 202 | 295 |
| Other Working Capital | 284 | 161 | N/A | -816 | -297 |
| Other Operating Activity | -313 | 162 | 0 | 1,493 | 1,115 |
| Operating Cash Flow | $-402 | $-154 | $N/A | $-1,349 | $-689 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -76 | -11 | N/A | -631 | -494 |
| Other Investing Activity | 0 | 0 | 0 | 125 | 83 |
| Investing Cash Flow | $-76 | $-11 | $N/A | $-506 | $-411 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 50 | N/A | N/A | N/A | N/A |
| Debt Issued | 370 | 177 | N/A | 1,464 | 433 |
| Debt Repayment | -17 | N/A | N/A | 110 | N/A |
| Other Financing Activity | 19 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $421 | $177 | $N/A | $1,574 | $433 |
| Beginning Cash Position | 75 | 75 | N/A | 754 | 754 |
| End Cash Position | 0 | 77 | N/A | 382 | 93 |
| Net Cash Flow | $-75 | $2 | $N/A | $-372 | $-661 |
| Free Cash Flow | |||||
| Operating Cash Flow | -402 | -154 | N/A | -1,349 | -689 |
| Capital Expenditure | -76 | -11 | N/A | -631 | -494 |
| Free Cash Flow | -478 | -165 | 0 | -1,979 | -1,182 |